Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib in Advanced Solid Tumors With FGFR Alteration
- Status
- UNKNOWN
- Phase
- NA
Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
- Status
- UNKNOWN
- Phase
- PHASE1
Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE4
Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC
- Status
- UNKNOWN
- Phase
- NA
Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- NA